STOCK TITAN

December 2022 Stock Gainers on News, Micro Caps Included

Ranked by the close-to-close change of the trading session each announcement landed in. How this is measured.

Data as of the trading session of , 20 of 21 completed market sessions produced ranked moves. That date is the last ranked session, not the last priced one, so follow-through dates run later.

On 100 of these rows the measured session was reconstructed from the announcement time, because it predates our stored session records.

See the biggest losers of December 2022 Every stock ranked by its December 2022 gain, with or without news

100

Ranked gains

+1007.59%

Largest, AMAM

89.9%

Above baseline, day +5

0.6%

Median give-back, day +5

Filter and sort
Rows

100 ranked gains in December 2022

Skip the ranked rows and go to the month summary

Every percentage on a row, the follow-through readings included, is measured against that row's own pre-news close, which the row names. A day +5 reading is therefore the move from before the announcement, not a further change on top of the headline percentage.

Rows are ordered by the move measured when the board was ranked. A percentage recomputed from the session's own closing prices can sit a little above or below its neighbours; the rank is the one the measured move gave the row.

Rank Symbol close to close Session Catalyst Announcement
1 AMAM +1007.59% against the close of 12/08/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Ambrx Announces Encouraging Preliminary Safety and Efficacy Data Evaluating ARX788 in HER2 Positive Metastatic Breast Cancer Patients Who Progressed Following T-DM1 Treatment

08:00 ET premarket

2 PHVS +356.57% against the close of 12/07/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Pharvaris Announces Positive Top-line Phase 2 Data from RAPIDe-1 Study of PHVS416 for the On-Demand Treatment of HAE Attacks

06:50 ET premarket

3 MDGL +268.07% against the close of 12/16/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Madrigal Pharmaceuticals To Announce Topline Results from the Phase 3 MAESTRO-NASH Study of Resmetirom on Monday, December 19th

16:00 ET after hours

4 KALA under $25M today +218.37% against the close of 12/27/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
FDA & Regulatory Kala Pharmaceuticals Announces FDA Acceptance of IND Application for KPI-012 for the Treatment of PCED

16:01 ET after hours

5 SMMT +194.27% against the close of 12/05/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Contract / Partnership Summit Therapeutics Partners with Akeso Inc. in Deal for Up to $5 Billion to In-License Breakthrough Innovative Bispecific Antibody

07:30 ET premarket

6 ICCM under $25M today Also on the opposite board this month on both boards +177.60% against the close of 12/19/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement IceCure's ProSense Safe and Effective in Treating Kidney Tumors with 89.5% Recurrence-Free Rate Based on Interim Study Results

16:05 ET after hours

7 RXDX More than one ranked move this month 2+ ranked moves +165.67% against the close of 12/06/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Prometheus Biosciences Announces Positive Results for PRA023 in Both ARTEMIS-UC Phase 2 and APOLLO-CD Phase 2a Studies Enabling Pathway to Both First-in-Class and Best-in-Class Anti-TL1A mAb

07:00 ET premarket

8 HOTH Also on the opposite board this month on both boards +143.64% against the close of 12/28/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
FDA & Regulatory Hoth Therapeutics Announces FDA Acceptance of IND Application for HT-001 for the Treatment of Cancer Disorders Associated with Epidermal Growth Factor Receptor (EGFR) Inhibitor Therapy

08:45 ET premarket

9 MAXR +124.81% against the close of 12/15/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
M&A / Acquisition Maxar Technologies To Be Acquired by Advent International for $6.4 Billion

07:00 ET premarket

10 ICVX +112.38% against the close of 12/13/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Icosavax Reports Positive Durability Data for VLP Vaccine Candidate IVX-121 Against RSV at Six-Month Timepoint

16:05 ET after hours

11 VLON +104.69% against the close of 12/13/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
M&A / Acquisition Vallon Pharmaceuticals and GRI Bio Enter into Merger Agreement with Goal of Advancing Innovative Pipeline of NKT Cell Regulators

16:05 ET after hours

12 SLNO +103.86% against the close of 12/16/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Soleno Therapeutics Announces Financing Commitment for up to $60 Million

08:00 ET premarket

13 ISO Same release as rank 72 +102.87% against the close of 12/21/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
M&A / Acquisition Berkeley Lights to Acquire IsoPlexis, Creating a Premier Functional Cell Biology Company

16:15 ET after hours

14 QUMU +100.00% against the close of 12/16/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
M&A / Acquisition Enghouse Systems to Acquire Qumu Corporation in All-Cash Transaction Expanding its SaaS Enterprise Video Offering

07:20 ET premarket

15 TIG +91.51% against the close of 12/15/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
M&A / Acquisition Trean Insurance Group Announces Definitive Agreement to be Acquired by Altaris Capital Partners

08:00 ET premarket

16 RENT +74.26% against the close of 12/07/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Rent the Runway, Inc. Announces Third Quarter 2022 Results & Raises Guidance

16:01 ET after hours

17 CLRO under $25M today +73.40% against the close of 12/08/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Joint Press Release of Settlement Between ClearOne and Shure

08:00 ET premarket

18 CORZ Also on the opposite board this month on both boards +69.72% against the close of 12/13/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Crypto & Treasury B. RILEY FINANCIAL ISSUES OPEN LETTER TO CORE SCIENTIFIC INVESTORS

13:58 ET intraday

19 IMV Also on the opposite board this month on both boards +66.55% against the close of 12/14/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results IMV Inc. Announces Initial Data from the Ongoing Phase 2B VITALIZE Trial in Patients with r/r DLBCL

07:05 ET premarket

20 APCX under $25M today +66.27% against the close of 12/21/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement AppTech Payments Corp. Holds Fireside Chat with Fox Business Network Market Analyst Kenny Polcari

17:15 ET after hours

21 PRQR +63.64% against the close of 12/21/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Contract / Partnership catalyst from a later release the same session ProQR Announces Conference Call to Discuss Axiomer® RNA Editing Platform

06:15 ET premarket

22 PALI +61.49% against the close of 12/29/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution Rose on dilution Palisade Bio Announces $2.5 Million Registered Direct Offering and Concurrent Private Placement Priced Above Market Under Nasdaq Rules

08:45 ET premarket

23 ORIC +59.67% against the close of 12/21/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results ORIC Pharmaceuticals Announces Clinical Development Collaboration with Pfizer for ORIC-533 in Multiple Myeloma and Concurrent $25 Million Equity Investment by Pfizer

17:48 ET after hours

24 PAFO +59.01% against the close of 12/05/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Reverse Merger / Shell Pacifico Acquisition Corp. Stockholders Approve Proposed Merger Transaction with Caravelle

17:00 ET after hours

25 SINT under $25M today +57.16% against the close of 12/20/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results SINTX TECHNOLOGIES AWARDED PHASE I CONTRACT FROM THE MISSILE DEFENSE AGENCY FOR ELECTROCHEMICAL MACHINING

09:00 ET premarket

26 REKR +56.45% against the close of 12/20/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution (terminated) Rose on dilution Rekor Terminates "At-The-Market" Facility

13:00 ET intraday

27 FFIE Also on the opposite board this month on both boards +55.53% against the close of 12/09/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Faraday Future to Host Virtual Global Investor Business Update on Thursday, December 15th, 2022

23:00 ET after hours

28 RNA +55.28% against the close of 12/13/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Avidity Announces Positive AOC 1001 Phase 1/2 MARINA™ Data Demonstrating First-Ever Successful Targeted Delivery of RNA to Muscle - Revolutionary Advancement for the Field of RNA Therapeutics

07:00 ET premarket

29 CENN under $25M today +51.86% against the close of 12/20/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Cenntro Begins Shipments of LS260 and LS100 Vans to European Markets

08:31 ET premarket

30 GRRR +47.25% against the close of 12/27/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution Rose on dilution Gorilla Technology Group Wraps up Successful 2022 by Entering MENA Region with Security Convergence Offering in Multi-Year, Multi-Million Dollar Deal

17:00 ET after hours

31 MFH release reads negative +45.59% against the close of 12/28/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Release reads negative, stock rose 45.59% Mercurity Fintech Holding Inc. Reports First Half 2022 Financial Results

08:30 ET premarket

32 NYMX +44.81% against the close of 12/02/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement NYMOX Announces New Marketing Submission for NYMOZARFEX™ for BPH

09:30 ET intraday

33 CPHI release reads negative +44.38% against the close of 12/02/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
M&A / Acquisition catalyst from a later release the same session Release reads negative, stock rose 44.38% China Pharma Announces Receipt of Noncompliance Notice from NYSE American

16:10 ET after hours

34 IMBIL +43.23% against the close of 12/22/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
M&A / Acquisition iMedia Brands Signs Agreement to Sell Three Buildings For $48 Million

16:00 ET after hours

35 VOR +41.86% against the close of 12/06/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution Rose on dilution Vor Bio Prices Underwritten Offering of Common Stock and Concurrent Private Placement for Aggregate Proceeds of $115.8 Million

07:45 ET premarket

36 IPHA +39.47% against the close of 12/16/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Contract / Partnership Sanofi and Innate Pharma Expand Collaboration for Natural Killer Cell Therapeutics in Oncology

01:00 ET premarket

37 KINS +39.45% against the close of 12/09/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Contract / Partnership Kingstone Announces Exchange Agreement for Debt Refinancing

08:00 ET premarket

38 LUCY under $25M today +38.99% against the close of 12/27/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Contract / Partnership Innovative Eyewear, Inc. Announces Multi-Year, Global Licensing Agreement with Authentic Brands Group for Eddie Bauer® Smart Eyewear

07:00 ET premarket

39 EXPR +38.28% against the close of 12/07/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Express, Inc. Reports Third Quarter 2022 Results

06:00 ET premarket

40 VRNA +37.81% against the close of 12/19/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Verona Pharma to Announce Top-line Data from Phase 3 ENHANCE-1 Trial of Nebulized Ensifentrine for COPD

16:01 ET after hours

41 EVOK under $25M today +36.70% against the close of 12/06/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement USPTO Grants New Patent to Evoke Pharma Covering the Usage of GIMOTI® To Treat Moderate to Severe Gastroparesis

08:30 ET premarket

42 BYSI +35.94% against the close of 12/12/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement BeyondSpring Presents Positive Data with Plinabulin for the Prevention of Docetaxel-Induced Neutropenia in Patients with Non-Small Cell Lung Cancer and Breast Cancer at Three Medical Conferences

08:00 ET premarket

43 AVXL Also on the opposite board this month on both boards +35.85% against the close of 12/01/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results ANAVEX®2–73 (Blarcamesine) Phase 2B/3 Study Met Primary and Key Secondary Endpoints, Showing Statistically Significant Reduction of Clinical Decline in Global Clinical Study of Patients With Early Alzheimer’s Disease

20:26 ET after hours

44 BCLI under $25M today +35.77% against the close of 12/09/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement BrainStorm Cell Therapeutics Submits Type A Meeting Request to U.S. Food and Drug Administration

07:00 ET premarket

45 CFMS +35.00% against the close of 11/30/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Uplisting / Compliance Conformis, Inc. Regains Compliance with Nasdaq’s Minimum Bid Price Rule

16:30 ET after hours

46 COSM Also on the opposite board this month on both boards +34.49% against the close of 12/01/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Cosmos Health Provides a Summary Regarding Recent Share Activity and Reiterates its Belief and Commitment to the Financial Strength and the Growth and Profitability of the Company

15:10 ET intraday

47 EH +34.27% against the close of 12/02/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Leadership Change EHang Holdings Limited Announces Appointment of Nick Ning Yang as New Independent Director

07:27 ET premarket

48 JNCE +33.79% against the close of 12/27/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
M&A / Acquisition Gilead To Acquire All Remaining Rights To Potential First-In-Class Immunotherapy GS-1811 From Jounce Therapeutics

16:30 ET after hours

49 CHRA +33.35% against the close of 12/29/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Charah Solutions, Inc. Receipt of Notification Letter from NYSE

06:55 ET premarket

50 WVE +32.69% against the close of 12/12/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Contract / Partnership Wave Life Sciences and GSK Announce Collaboration to Drive Discovery and Development of Oligonucleotide Therapeutics Focusing on Novel Genetic Targets

07:30 ET premarket

51 VVNT +32.37% against the close of 12/05/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
M&A / Acquisition NRG Energy, Inc. to Acquire Vivint Smart Home, Inc.

06:01 ET premarket

52 KTRA under $25M today +32.24% against the close of 11/30/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Kintara Therapeutics to Participate at the RHK Capital Disruptive Growth Conference on December 5-6, 2022

08:00 ET premarket

53 SLNH Also on the opposite board this month on both boards +31.57% against the close of 12/20/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Soluna Receives Green Light from Regulator for Flagship Texas Data Center

08:30 ET premarket

54 LANV +31.06% against the close of 12/15/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Lanvin Group Debuts on NYSE under Ticker "LANV"

16:30 ET after hours

55 IINN under $25M today +30.33% against the close of 12/13/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Inspira™ Technologies Signs Agreement to Conduct Clinical Study of HYLA™ Blood Sensor

09:00 ET premarket

56 NAAS +30.10% against the close of 12/29/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Leadership Change NaaS Technology Inc. Announces Appointment of Alex Wu as Chief Financial Officer, President and Director

07:56 ET premarket

57 LASE +29.64% against the close of 12/20/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Contract / Partnership Laser Photonics Receives Order From The Largest Glass Manufacturer In North America

07:00 ET premarket

58 FORA +29.36% against the close of 12/20/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement New York Selects BioTrack as the State's Cannabis Track and Trace System

18:37 ET after hours

59 MOMO +29.33% against the close of 12/07/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Hello Group Inc. Announces Unaudited Financial Results for the Third Quarter of 2022

01:23 ET premarket

60 ACLX +29.24% against the close of 12/08/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Contract / Partnership Arcellx and Kite Announce Strategic Collaboration to Co-Develop and Co-Commercialize Late-Stage Clinical CART-ddBCMA in Multiple Myeloma

08:15 ET premarket

61 POL release reads negative +28.07% against the close of 12/21/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Leadership Change Release reads negative, stock rose 28.07% Polished.com Announces Internal Investigation Results, Corporate Updates and the Board of Directors’ Remedial Actions

08:00 ET premarket

62 IFRX +27.96% against the close of 12/20/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Contract / Partnership InflaRx Announces Amendment of Co-Development Agreement and Additional Equity Investment by Staidson in Connection with Regulatory Filing in China for Anti-C5a-Antibody for Treatment of COVID-19

07:30 ET premarket

63 DGICB +27.35% against the close of 12/14/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Buyback / Dividend Donegal Group Inc. Announces Quarterly Dividend

15:57 ET intraday

64 BIVI under $25M today +26.67% against the close of 12/06/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement BioVie Issues Letter to Shareholders

08:00 ET premarket

65 COUP +26.67% against the close of 12/09/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
M&A / Acquisition Coupa Software Enters into Definitive Agreement to Be Acquired by Thoma Bravo for $8 Billion

07:00 ET premarket

66 IFBD under $25M today +26.67% against the close of 12/08/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Infobird Co., Ltd Announces Receipt of Delinquency Notification Letter from Nasdaq

17:00 ET after hours

67 SPB +26.62% against the close of 12/01/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Spectrum Brands’ Statement on ASSA ABLOY’s Proposed Sale of its Emtek and Smart Residential Business in the U.S. and Canada

00:15 ET premarket

68 OKTA release reads negative +26.46% against the close of 11/30/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Release reads negative, stock rose 26.46% Okta Announces Third Quarter Fiscal Year 2023 Financial Results

16:01 ET after hours

69 CELC +26.36% against the close of 12/07/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Celcuity Announces First Patient Dosed in Phase 3 VIKTORIA-1 Clinical Trial of Gedatolisib for the Treatment of HR+/HER2- Advanced Breast Cancer

16:00 ET after hours

70 FLNC +26.34% against the close of 12/12/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Fluence Energy, Inc. Reports Fourth Quarter and Full Fiscal Year 2022 Financial Results  

17:15 ET after hours

71 ARCE +25.77% against the close of 11/30/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Arco Announces Receipt of Non-Binding Going Private Proposal

20:43 ET after hours

72 BLI Same release as rank 13 +24.69% against the close of 12/21/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
M&A / Acquisition Berkeley Lights to Acquire IsoPlexis, Creating a Premier Functional Cell Biology Company

16:15 ET after hours

73 TAYD +24.07% against the close of 12/28/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings TAYLOR DEVICES ANNOUNCES SECOND QUARTER AND SIX-MONTH RESULTS

08:52 ET premarket

74 PDSB under $25M today +23.78% against the close of 12/27/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results PDS Biotech Reports Median Overall Survival (OS) of 21 Months in Advanced, Refractory Cancer Patients Having Few Remaining Treatment Options and with Reported Historical Survival of 3-4 months

08:00 ET premarket

75 CIH +23.72% against the close of 12/21/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Contract / Partnership China Index Holdings Enters into Definitive Agreement for Going-Private Transaction

07:50 ET premarket

76 LIAN +23.70% against the close of 12/16/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Pfizer Opts In to LianBio Rights to Respiratory Syncytial Virus Therapeutic Candidate Sisunatovir in Mainland China, Hong Kong, Macau, and Singapore

07:00 ET premarket

77 ZYME +23.59% against the close of 12/20/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Contract / Partnership catalyst from a later release the same session Zymeworks Announces Participation in Upcoming Investor Conference

07:30 ET premarket

78 HYMC +23.48% against the close of 12/19/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement HYCROFT CONTINUES DRILLING HIGHER GRADES

08:00 ET premarket

79 IMMX +23.29% against the close of 12/13/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Immix Biopharma in-licenses NXC-201, BCMA-targeted Next-Generation CAR-T Therapy Demonstrating High Complete Response Rate in Heavily Pre-Treated Multiple Myeloma (71% Complete Responses) and AL Amyloidosis (100% Complete Responses)

08:00 ET premarket

80 WEBR +23.23% against the close of 12/09/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
M&A / Acquisition Weber Inc. to Be Taken Private by BDT Capital Partners for $8.05 Per Share

07:16 ET premarket

81 MDB +23.23% against the close of 12/06/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings MongoDB, Inc. Announces Third Quarter Fiscal 2023 Financial Results

16:05 ET after hours

82 TGB +23.20% against the close of 12/19/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Contract / Partnership TASEKO AND MITSUI ENTER STRATEGIC PARTNERSHIP TO DEVELOP FLORENCE COPPER

08:30 ET premarket

83 ARBK Also on the opposite board this month on both boards +23.19% against the close of 12/28/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Crypto & Treasury Argo Blockchain PLC Announces Closing of Transactions - Galaxy Digital Holdings

02:00 ET premarket

84 CAMP +22.74% against the close of 12/20/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings CalAmp Reports Third Quarter Fiscal Year 2023 Financial Results

16:05 ET after hours

85 HARP +22.61% against the close of 12/09/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Harpoon Therapeutics Presents Updated Interim Results at ASH 2022 for Novel T Cell Engager HPN217 in Relapsed/Refractory Multiple Myeloma

10:00 ET intraday

86 FOA +22.50% against the close of 12/06/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
M&A / Acquisition Finance of America to Acquire Assets of Reverse Mortgage Lender AAG

07:00 ET premarket

87 NILE +22.50% against the close of 12/29/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Ault Alpha Has Purchased 50 Million Shares of Common Stock of BitNile Holdings, Inc.

06:30 ET premarket

88 HILS +22.36% against the close of 11/30/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Contract / Partnership Hillstream BioPharma Announces Development of Proprietary Targeted Biologics, Knob Quatrabodies™ (HSB-1940) against PD-1, by combining Quatramers™ with OmniAb’s Picobodies™, via a Collaboration Agreement, against Novel, Unreachable and Undruggable Epitopes in High Value Validated Targets

08:47 ET premarket

89 RXDX More than one ranked move this month 2+ ranked moves +22.35% against the close of 12/07/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution Rose on dilution Prometheus Biosciences, Inc. Announces Proposed Public Offering of Common Stock

16:01 ET after hours

90 CERE +22.33% against the close of 12/16/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Cerevel Therapeutics Announces Positive Results in Emraclidine Ambulatory Blood Pressure Monitoring Trial

06:30 ET premarket

91 REPL +22.23% against the close of 12/06/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Replimune Announces Positive Initial Data from the Anti-PD1 Failed Melanoma Cohort of the IGNYTE Clinical Trial & an RP2/3 Program Update

07:00 ET premarket

92 DBVT +22.03% against the close of 12/22/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
FDA & Regulatory DBV Technologies Announces FDA Has Lifted Partial Clinical Hold on VITESSE Phase 3 Pivotal Trial  

01:30 ET premarket

93 SFT +21.90% against the close of 12/08/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
M&A / Acquisition Shift Closes Merger with CarLotz, Creating a Differentiated Used Omnichannel Auto Retailer, and Announces Shift Board of Directors Changes

09:00 ET premarket

94 RIGL +21.84% against the close of 12/01/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
FDA & Regulatory Rigel Announces U.S. FDA Approval of REZLIDHIA™ (olutasidenib) for the Treatment of Adult Patients with Relapsed or Refractory Acute Myeloid Leukemia with a Susceptible IDH1 Mutation

17:03 ET after hours

95 OTLK +21.81% against the close of 12/22/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Contract / Partnership Outlook Therapeutics® Enters Definitive Agreement for $31.8 Million Unsecured Convertible Promissory Note

09:00 ET premarket

96 BRSH under $25M today Also on the opposite board this month on both boards +21.65% against the close of 12/09/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution Rose on dilution Aegis Capital Corp. Acted as Exclusive Placement Agent on a $3.0 Million Private Placement for Bruush Oral Care Inc. (NASDAQ:BRSH)

11:00 ET intraday

97 DLNG +21.29% against the close of 12/29/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Dynagas LNG Partners LP Announces New Time Charter for the LNG Carrier Arctic Aurora

09:00 ET premarket

98 TMDI Also on the opposite board this month on both boards +21.08% against the close of 12/06/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Titan Medical Suspends Special Meeting of Shareholders in Conjunction with Initiation of Strategic Review Process

07:30 ET premarket

99 BXRX +20.77% against the close of 12/07/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Baudax Bio Initiates Phase II Clinical Trial Evaluating BX1000 in Patients Undergoing Surgery

08:00 ET premarket

100 SESN +20.67% against the close of 12/29/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
M&A / Acquisition Sesen Bio and Carisma Therapeutics Announce Substantial Increase to Expected Special Cash Dividend in Connection with Pending Merger

16:33 ET after hours

NYSE and Nasdaq companies with a market capitalization of $5M or more, measured today, including the $5M to $25M band. The exchange is the one recorded on each announcement, and a release naming several tickers records one venue for all of them. A session that changed hands for less than $25,000 in total is not ranked, because a percentage set by a handful of shares is a print rather than a move. On a board older than a year a fund is identified by its name alone, because an instrument class describes whoever holds the ticker today. 227 events never entered this month's eligible pool, because the ticker is a warrant, a unit, a right or a preferred rather than common stock, or carries a stored capitalization above $10 trillion, which is larger than any company has reached. Exclude the $5M to $25M band

2 candidate events for this board could not be anchored to a trading session and are not listed.

2 events were left out of this board because the vendor names the ticker as a preferred, a note, a depositary share or a fund rather than a company's common stock.

2 events were left out of this board because the measured session changed hands for less than $25,000 in total, so the percentage prices a handful of shares rather than a move anyone could have taken.

Company names are not shown on months older than a year, because only the current holder of each ticker is known.

In December 2022, the median gainer had given back 0.6% of its move five sessions later; the largest catalyst group was Other Announcement, 27 of the 100 events, at a median of +33.4%.

Close-to-close change on the measured trading session, against the previous close.

NYSE and Nasdaq companies with a market capitalization of $5M or more, measured today, including the $5M to $25M band. The exchange is the one recorded on each announcement, and a release naming several tickers records one venue for all of them. A session that changed hands for less than $25,000 in total is not ranked, because a percentage set by a handful of shares is a print rather than a move. On a board older than a year a fund is identified by its name alone, because an instrument class describes whoever holds the ticker today.

Which catalysts drove the board

Swipe the table sideways for the day +5 columns.

Catalyst Events Share of board Median move close to close Median at day +5 Still above the pre-news close at day +5
Other Announcement 27 27.0% +33.4% +40.1% of 26 88.5% of 26
Clinical Trial Results 16 16.0% +36.8% +41.4% 81.3% of 16
M&A / Acquisition 15 15.0% +33.8% +31.5% 93.3% of 15
Contract / Partnership 14 14.0% +29.4% +35.4% 100.0% of 14
Earnings 10 10.0% +26.4% +28.2% 90.0% of 10

The day +5 figures are measured over the events in each group that have a five-session close, the count printed beside them, not over every event in the group.

7 other catalyst types, 18 events: Offering / Dilution, FDA & Regulatory, Leadership Change, Crypto & Treasury, Reverse Merger / Shell, Uplisting / Compliance, Buyback / Dividend.

How much of the move survived

Horizon Still above the pre-news close close to close Median change since the measured close as a share of the move
Day +1 98.0% of 99 0.0% given back, of 99
Day +5 89.9% of 99 0.6% given back, of 99
Month end 86.0% of 93 0.0% given back, of 93
Month end falls before day +5 for 12 of these 93 events, so this row is not a later horizon than the one above it. 93 of the 100 events have a month-end close later than the measured session; 6 have it on the measured session itself, and 1 has no month-end close.

Both figures in a row are measured over the events that have a close at that horizon, the count printed beside each of them, not over all 100 events on this board, which is why the denominators differ between rows.

Repeat runners

Some companies move on news more than once. The left list holds the ones that moved twice or more this month; the right list holds the ones that also moved in the months before it. The ranking above shows one row per move, so a name that keeps coming back is only visible here.

Moved twice or more inside December 2022

Two or more ranked moves this month, each on a different trading day.

SymbolMeasured sessionsBest move
RXDX 2Clinical Trial Results, Offering / Dilution +165.67%

Also risen on news in earlier months

Ranked in at least two of the three months before this one. They are listed whether or not they rank this month, which is why the months are named.

SymbolMonthsBest move
BCAN 2022-11, 2022-10, 2022-09 +37.06%
PALIthis month too 2022-11, 2022-09 +81.90%
INM 2022-11, 2022-09 +70.42%
PRPL 2022-11, 2022-09 +39.43%
NRBO 2022-11, 2022-09 +47.21%
PRVB 2022-11, 2022-10 +26.09%
ISEE 2022-11, 2022-09 +66.31%
AKUS 2022-10, 2022-09 +88.16%
NUVL 2022-10, 2022-09 +60.64%
BEAT 2022-10, 2022-09 +85.60%
NTNX 2022-10, 2022-09 +29.13%
USEA 2022-10, 2022-09 +20.99%
RETA 2022-10, 2022-09 +21.06%
LITM 2022-10, 2022-09 +38.26%
TC 2022-10, 2022-09 +19.06%

What the board was made of

Price before the move

Price bands are not shown on months older than a year, because the stored prices are adjusted for splits done since and a company that has reverse-split lands in a band its shares never traded in.

When the announcement landed

  • Pre-market62.0%
  • Intraday7.0%
  • After hours31.0%

Volume against normal

  • Under 5x15 events, 15.3%
  • 5x to 20x26 events, 26.5%
  • Over 20x57 events, 58.2%

2 events have too little trading history for a relative volume, and are not in the tiers above.

Industry

  • Pharmaceutical Preparations20 events, 20.0%
  • Biological Products, (no Diagnostic Substances)7 events, 7.0%
  • Miscellaneous Electrical Machinery, Equipment & Supplies3 events, 3.0%
  • Services-prepackaged Software3 events, 3.0%
  • Finance Services2 events, 2.0%
  • Fire, Marine & Casualty Insurance2 events, 2.0%

13 other industries, 14 events

Industry not known: 49.0%

4 events on this board carry the flag for a move that ran against its own release, too few to say whether the flag predicts anything.

Against November 2022

100 events in the comparable window.

November 2022 median +32.1%, selected from the 10,949 events in that month's eligible pool

December 2022 median +32.5%, 0.4 points above November 2022. December 2022's median is taken over the 100 ranked rows, selected from the 6,358 events in that month's eligible pool.

The two windows drew on pools of very different size, so part of the gap between the medians is how deep into each pool the top hundred reaches rather than how severe the moves were.

How this ranking is measured

Close-to-close change on the measured trading session, against the previous close.

  • An announcement before 16:00 ET is measured on that trading day; one at or after 16:00 ET, or on a weekend, is measured on the next trading day.
  • One row per company and measured session. Other announcements the company made in the same session are listed inside the row.
  • A ranking is a coincidence of news and price on the same session, not proof that the news caused the move. Part of an intraday move can precede the announcement.
  • No Stated Cause marks a release in which the company itself says it knows of no reason for the move, while Other Announcement marks a release these rules could not classify.

Eligibility uses each company's capitalization today, not its capitalization at the time. Archive boards can therefore change as companies grow or shrink.

Prices are adjusted for stock splits the company has done since, so an older row's dollar figures are stated on today's share count and are not the prices that traded that day. The percentage move, the dollar volume and the relative volume are unaffected, because both prices carry the same adjustment. The session's share count carries the adjustment too, so the shares figure beside the dollar volume is that count restated on today's basis rather than the number of shares that changed hands. Where the ticker was retired the price series stops with it and no later adjustment reached it, so those rows are marked as traded and their dollars are the ones that changed hands on the day.

Market cap is not shown on months older than a year, because only today's figure exists.

NYSE and Nasdaq companies with a market capitalization of $5M or more, measured today, including the $5M to $25M band. The exchange is the one recorded on each announcement, and a release naming several tickers records one venue for all of them. A session that changed hands for less than $25,000 in total is not ranked, because a percentage set by a handful of shares is a print rather than a move. On a board older than a year a fund is identified by its name alone, because an instrument class describes whoever holds the ticker today.

On 100 of these rows the measured session was reconstructed from the announcement time, because it predates our stored session records.

This archive starts at 2020-04, the first month with ranked moves.